NEUROLOGY

NEUROLOGY

Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday?

In a significant development that has sent shockwaves through the healthcare sector, Denmarkbased H. Lundbeck A/S has announced its intention to acquire Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) for $60.00 per share in cash. This acquisition, valued at approximately $2.6 billion in equity and $2..

NEUROLOGY

Longboard Pharmaceuticals Stock Soars 51%. It’s Being Bought for $2.6 Billion.

In a significant development in the pharmaceutical industry, Danish company H Lundbeck A/S has agreed to acquire U.S.based Longboard Pharmaceuticals in a $2.6 billion deal..

NEUROLOGY

Millennium Management LLC Acquires 128,743 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)

Introduction In a significant move in the pharmaceutical industry, Millennium Management LLC has increased its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) by a staggering 395.1% during the second quarter. This acquisition reflects a growing interest in the company's innovative treatments and potential for future growth..